2000
DOI: 10.1007/978-1-4615-4649-8_16
|View full text |Cite
|
Sign up to set email alerts
|

Hyperglycemia and Diabetes — Induced Vascular Dysfunction: Role of Oxidative Stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
8
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 116 publications
0
8
0
Order By: Relevance
“…In addition, we have demonstrated that acetylcholine-induced vasodilation is decreased in epineurial arterioles from both streptozotocin-induced diabetic rats (an animal model of insulin deficiency and type 1 diabetes) and ZDF-fa/fa diabetic rats (an animal model of insulin resistance, hyperlipidemia, and type 2 diabetes) (Coppey et al 2000(Coppey et al , 2002Coppey, Gellett, Davidson, Dunlap, Lund, Salvemini et al 2001). Impaired endotheliumdependent vasodilation has been demonstrated in multiple vascular beds from different animal models of diabetes and in humans with type 1 or type 2 diabetes (Pieper 2000;Giugliano et al 1996;De Vriese, Verbeuren et al 2000). The mechanisms responsible for impaired vascular function in diabetes and how diabetes alters the biological activity of NO and EDHF are not well understood.…”
mentioning
confidence: 94%
“…In addition, we have demonstrated that acetylcholine-induced vasodilation is decreased in epineurial arterioles from both streptozotocin-induced diabetic rats (an animal model of insulin deficiency and type 1 diabetes) and ZDF-fa/fa diabetic rats (an animal model of insulin resistance, hyperlipidemia, and type 2 diabetes) (Coppey et al 2000(Coppey et al , 2002Coppey, Gellett, Davidson, Dunlap, Lund, Salvemini et al 2001). Impaired endotheliumdependent vasodilation has been demonstrated in multiple vascular beds from different animal models of diabetes and in humans with type 1 or type 2 diabetes (Pieper 2000;Giugliano et al 1996;De Vriese, Verbeuren et al 2000). The mechanisms responsible for impaired vascular function in diabetes and how diabetes alters the biological activity of NO and EDHF are not well understood.…”
mentioning
confidence: 94%
“…Studies using several types of diabetic rodent models have demonstrated impaired endothelial-dependent relaxation in both conduit and resistance arteries (4). Various factors have been proposed to contribute to this defect, including increased release of an endothelium-derived constricting factor, increased protein kinase C activity, inhibition of Na ϩ /K ϩ ATPase activity, a deficiency of substrate or cofactors for nitric oxide synthase, increased quenching of nitric oxide by advanced glycosylation end products, decreased nitric oxide release and decreased nitric oxide availability caused by increased quenching by superoxide, and subsequent formation of peroxynitrite (4). Studies showing that treatment with antioxidants prevents diabetes and hyperglycemia-induced impairment of endothelium-dependent relaxation suggest that oxidative stress is a major factor in the development of diabetic vascular disease (4,10 -23).…”
mentioning
confidence: 99%
“…Both diabetes mellitus and hyperhomocysteinaemia (HH) are risk factors for cardiovascular disease (CVD) [1,2] and are associated with impaired endothelial nitric oxide and with excess superoxide (O 2 -) formation [3,4,5,6,7,8,9,10,11]. Clinically, there are now a number of studies indicating that homocysteine (Hcy) potentiates CVD in diabetic patients [2].…”
mentioning
confidence: 99%
“…Since reduced nitric oxide formation is associated with vascular disease [5,6], the pathogenic impact of Hcy could be mediated, in part, through an O 2 --mediated reduction of NO bioavailability [4,5]. Similarly, diabetes mellitus is also associated with impaired endothelial function and reduced nitric oxide formation as well as increased O 2 -generation by the vasculature [7,8,9,10,11].…”
mentioning
confidence: 99%